Background and purpose: Evidence-based data to guide the management of status epilepticus (SE) after failure of primary treatment are still scarce and the alternate needs to be found when phenytoin (PHT) is not available or contraindicated. Comparison of intravenous (IV) valproate (VPA) and diazepam (DZP) infusion has not been conducted in adults with SE. This prospective randomized controlled trial is thus designed to evaluate the relative efficacy and safety of IV VPA and continuous DZP infusion as second-line anticonvulsants.
基金：
the capital medicine development committee foundation.
第一作者机构：[1]Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China
通讯作者：
通讯机构：[*]Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
推荐引用方式(GB/T 7714)：
W. B. Chen,R. Gao,Y. Y. Su,et al.Valproate versus diazepam for generalized convulsive status epilepticus: a pilot study[J].EUROPEAN JOURNAL OF NEUROLOGY.2011,18(12):1391-1396.doi:10.1111/j.1468-1331.2011.03420.x.
APA：
W. B. Chen,R. Gao,Y. Y. Su,J. W. Zhao,Y. Z. Zhang...&C. Q. Fan.(2011).Valproate versus diazepam for generalized convulsive status epilepticus: a pilot study.EUROPEAN JOURNAL OF NEUROLOGY,18,(12)
MLA：
W. B. Chen,et al."Valproate versus diazepam for generalized convulsive status epilepticus: a pilot study".EUROPEAN JOURNAL OF NEUROLOGY 18..12(2011):1391-1396
